Heat shock proteins and their use as anticancer vaccines.
about
Modulation of Akt and ERK1/2 pathways by resveratrol in chronic myelogenous leukemia (CML) cells results in the downregulation of Hsp70Induction of tumor-specific immune response by gene transfer of Hsp70-cell-penetrating peptide fusion protein to tumors in mice.Inducible heat shock protein 70 expression as a potential predictive marker of metastasis in breast tumors.Proteomics: a strategy to understand the novel targets in protein misfolding and cancer therapy.Cancer and innate immune system interactions: translational potentials for cancer immunotherapy.Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?Current ideas about applications of heat shock proteins in vaccine design and immunotherapy.Expression of heat shock protein 70 in nasopharyngeal carcinomas: different expression patterns correlate with distinct clinical prognosisTherapeutic aspects of chaperones/heat-shock proteins in neuro-oncology.Heat shock protein 70 regulates Tcl1 expression in leukemia and lymphomas.Vaccination: role in metastatic melanoma.Heat-shock protein-peptide complex-96 for the treatment of cancer.Vaccine therapy for renal cancer.Heat-shock proteins as powerful weapons in vaccine development.Grp94 in complexes with IgG is a soluble diagnostic marker of gastrointestinal tumors and displays immune-stimulating activity on peripheral blood immune cells.Cancer vaccine by fusions of dendritic and cancer cells.Molecular chaperones and protein-folding catalysts as intercellular signaling regulators in immunity and inflammation.Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors.Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer.Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.
P2860
Q28472533-3565EC27-B729-4F0B-B0B5-ED0E9F603741Q33730763-02727B56-8DF8-4254-BB1A-C953B1781092Q34451153-E01FBC10-26CD-4CE1-8E54-61414A6DD523Q35116243-03145585-1B15-4265-850F-9883050924A3Q35902972-E177F24C-263B-4B06-87CF-DE73CB5ABAD0Q36150417-C93BB521-0954-4E26-9F4F-539EEDFBEC9DQ36336642-A92F1EEA-FB99-4B09-9CAD-1EFDDF5407FEQ36338606-98B24E0E-5772-40BC-AD73-46B79502E5CFQ36499222-E3949031-EFF4-4C5B-9604-1ED1E192C24AQ36529496-D8162CD7-0239-43E1-9F70-F1F03535CEBFQ36573868-D9666AAB-2C1C-4105-B3DC-1DEFF6A509C0Q36909395-1669CD4A-C41A-49E9-AE55-8E39D8D89AECQ37259586-9E7725CA-8C2D-4B13-A1B9-05A5A386E258Q37290102-F927277A-B439-4502-AF65-0D72742C7753Q37687316-7ED76433-C299-4C39-AF8E-1972855F433CQ37698219-949FEAFC-4C1D-43E3-A548-4A28636C2FA4Q37743010-55B49206-9460-4E56-B214-6D63839CE860Q37813152-536B3F54-7E82-48FF-8254-F92824D61205Q38244094-2C4D9F08-B292-4773-8BDA-FACB379900A1Q39963921-72392EC7-40EA-4864-BC05-59A9C198AEEA
P2860
Heat shock proteins and their use as anticancer vaccines.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Heat shock proteins and their use as anticancer vaccines.
@ast
Heat shock proteins and their use as anticancer vaccines.
@en
type
label
Heat shock proteins and their use as anticancer vaccines.
@ast
Heat shock proteins and their use as anticancer vaccines.
@en
prefLabel
Heat shock proteins and their use as anticancer vaccines.
@ast
Heat shock proteins and their use as anticancer vaccines.
@en
P2093
P50
P1476
Heat shock proteins and their use as anticancer vaccines
@en
P2093
Filiberto Belli
Giorgio Parmiani
Lorenzo Pilla
Mario R Sertoli
Pramod K Srivastava
Roberto Patuzzo
P304
P356
10.1158/1078-0432.CCR-04-1194
P407
P50
P577
2004-12-01T00:00:00Z